Articles from American College of Medical Toxicology

The American College of Medical Toxicology (ACMT) has issued a statement regarding Florida's SB 718 legislation that categorizes the reckless exposure of first responders to fentanyl as a second-degree felony. It is the position of ACMT that this type of legislation perpetuates misinformation, potentially hindering emergency responders' effectiveness and causing delays in life-saving care for overdose victims.

The American College of Medical Toxicology (ACMT) has issued a position statement in response to the recent paper by Shearston et al reporting their study found trace concentrations of metals and metalloids in tampons.

A collaboration between the American College of Medical Toxicology (ACMT) and the Center for Forensic Science Research and Education (CFSRE), “The 2023 Virtual Seminar in Forensic Toxicology: Expanding Worlds of Cannabinoids & Polydrug Exposures” is a two-day virtual seminar featuring distinguished industry experts addressing some of the most crucial topics affecting the medical and public health landscape today. Topics covered include cannabis and alternative cannabinoid impairment, and new research on medical legal death investigations involving polydrug exposures such as fentanyl, xylazine, benzodiazepines. Registration for this event is open. Continuing Medical Education (CME) credits are also available.

The American College of Medical Toxicology (ACMT) has released a position statement, “Mifepristone and Misoprostol are Not Controlled Dangerous Substances,” in advance of the Louisiana law labeling them as such going into effect on October 1st.

The American College of Medical Toxicology (ACMT) is pleased to announce their 2025 Annual Scientific Meeting (#ACMT2025) and Symposia taking place April 2 - 6 at the Fairmont Hotel in Vancouver, Canada. This five-day program featuring three pre-meeting activities in addition to the main conference, will provide attendees with the latest advancements in medical toxicology research with numerous opportunities for networking and engagement throughout.

The American College of Medical Toxicology (ACMT) was recently awarded a five-year, $1 million cooperative agreement with the Centers for Disease Control (CDC) to implement the “Strengthening the Public Health System and Services through a Capacity Building Assistance Program for Medical Toxicologists.”

The American College of Medical Toxicology (ACMT) Toxicology Investigators Consortium (ToxIC) Fentanyl Analog Study has detected the veterinary medication, medetomidine, in patients seen in the emergency department after an opioid overdose. Data from this study contributed to findings presented in a recent Morbidity and Mortality Weekly Report (MMWR) released by the Centers for Disease Control and Prevention.

American College of Medical Toxicology (ACMT) symposium will address the ethics, psychology, management, and global epidemiology of the suicidal patient through a toxicology lens.

The ACMT Annual Scientific Meeting (ASM) and Symposia, the American College of Medical Toxicology’s signature annual event, will take place at the Omni Shoreham Hotel in Washington, DC April 10 - 14. The event promises 5 days of dynamic programming, fascinating research, and entertaining activities.

Under a U.S. Food and Drug Administration (FDA) contract with the American College of Medical Toxicology (ACMT), the Toxicology Investigators Consortium (ToxIC) is expanding its Drug Overdose Toxico-Surveillance (DOTS) Reporting Program evaluating patients with opioid and stimulant overdoses.

Under a U.S. Food and Drug Administration (FDA) contract awarded to the American College of Medical Toxicology’s (ACMT), the Toxicology Investigators Consortium (ToxIC) will examine the real-world administration of naloxone by community members, fire and police departments, and emergency medical services (EMS) personnel.

The Centers for Disease Control and Prevention (CDC) has recently released its Fentanyl Study Dashboard, an innovative tool that utilizes data from the Toxicology Investigators Consortium (ToxIC), to track and monitor nonfatal overdose trends associated with fentanyl. This cutting-edge dashboard aims to provide vital insights to healthcare professionals, policymakers, and researchers, enabling them to respond effectively to the ongoing opioid crisis.